To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Melanoma; breast cancer

Mouse studies suggest extracellular matrix (ECM)-binding mAbs against PD-L1 and CTLA-4 could help treat melanoma and breast cancer without adverse side effects. The

Read the full 265 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE